Patented Medicines (Notice of Compliance) Regulations — 3
3 (1) The following definitions apply in this section and in section 4. identification number means a number, preceded by the letters “DIN”, that is assigned for a drug in accordance with subsection C.01.014.2(1) of the Food and Drug Regulations . ( identification numérique ) new drug submission means a new drug submission or an extraordinary use new drug submission as those terms are used in Division 8 of Part C of the Food and Drug Regulations , but excludes such a submission that is based solely on the change of name of the manufacturer. ( présentation de drogue nouvelle ) supplement to a new drug submission means a supplement to a new drug submission or a supplement to an extraordinary use new drug submission as those terms are used in Division 8 of Part C of the Food and Drug Regulations , but excludes such a supplement that is based solely on one or more of the matters mentioned in any of paragraphs C.08.003(2)(b) and (d) to (g) and subparagraphs C.08.003(2)(h)(iv) and (v) of those Regulations. ( supplément à une présentation de drogue nouvelle ) (2) The Minister shall maintain a register of patents that have been submitted for addition to the register and certificates of supplementary protection in which any of those patents are set out (a) by adding any patent on a patent list or certificate of supplementary protection that meets the requirements for addition to the register; (b) by refusing to add any patent or certificate of supplementary protection that does not meet the requirements for addition to the register; (c) by deleting any patent or certificate of supplementary protection (i) that was added to the register due to an administrative error, (ii) that has, under subsection 60(1) or 125(1) of the Patent Act , been declared to be invalid or void, (iii) that has, under subsection 6.07 (1), been declared to be ineligible for inclusion on the register, or (iv) the deletion of which was requested by the first person in respect of the patent list that includes that patent; (d) by deleting, in respect of a new drug submission or a supplement to a new drug submission, any patent that has expired, unless a certificate of supplementary protection in which the patent is set out is included on the register in respect of that submission or supplement; and (e) by deleting any certificate of supplementary protection that has expired. (2.1) The Minister is not permitted to make a deletion referred to in subparagraph (2)(c)(iii) based on a decision by the Federal Court before the later of the day on which the period for appealing that decision to the Federal Court of Appeal ends and the day on which any appeal of that decision to the Federal Court of Appeal is discontinued or dismissed. (2.2) The Minister shall add any patent or certificate of supplementary protection to the register that has been deleted under subparagraph (2)(c)(ii) or (iii) based on a decision that subsequently is reversed or set aside on appeal. (2.3) The Minister may review the register to determine whether any patents or certificates of supplementary protection do not meet the requirements for inclusion on the register and, if the Minister conducts that review, shall delete any patent or certificate of supplementary protection that is determined not to meet those requirements. (3) If a patent is listed on the register in respect of a new drug submission or supplement to a new drug submission for a drug for which the identification number has been cancelled under paragraph C.01.014.6(1)(a) of the Food and Drug Regulations , the Minister shall delete the patent from the register 90 days after the date of cancellation. (4) Subsection (3) does not apply if the identification number is cancelled under paragraph C.01.014.6(1)(a) of the Food and Drug Regulations because of a change in manufacturer. (5) If, after an identification number is cancelled under paragraph C.01.014.6(1)(a) of the Food and Drug Regulations , an identification number is assigned for the s